Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 19Recruiting 4Terminated 3Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 9CNS 7Gynecologic 5Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Retinoblastoma 1

Interventions

pembrolizumab 27Nivolumab 11Pemetrexed 10Cyclophosphamide 10Carboplatin 10atezolizumab 9Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6Injections 5tislelizumab 4spartalizumab 4fludarabine 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2tocilizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Topotecan × Other solid neoplasm × Clear all
NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
174 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡